HIGHLIGHTS
- who: Riccardo Mezzadra et al. from the Institute, Amsterdam, The Netherlands, Division of Cell Biology, The Netherlands Cancer Institute, Current address: Department of Medical Oncology, Leiden University Medical Center, Leiden, The have published the Article: SLFN11 can sensitize tumor cells towards IFN-#_#x03B3;-mediated T cell killing, in the Journal: PLOS ONE | https://doi.org/10.1371/journal.pone [0212053]. February 12, 2019 of /1371/
- what: The authors demonstrate that SLFN11 expression can regulate IFN-u03b3-mediated toxicity (Fig 2C-2E, 4A) and, as a consequence, sensitivity of tumor cells to T_cell attack (Fig . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.